Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroprotection and repair in multiple sclerosis.
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems.
Falls in people with MS-an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States.
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
[Multiple sclerosis and endothelial dysfunction (a review)].
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis-Reply.
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
Early onset (childhood) monogenic neuropathies.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
Human neural stem cells induce functional myelination in mice with severe dysmyelination.
Gait variability and multiple sclerosis.
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »